Christopher Y. Chai, Chief Financial Officer at MAP Pharmaceuticals, Inc. (MAPP), sold 16,000 shares at $12.42 ($203K) on 2010-07-20, disclosed to the SEC on 2010-07-22.
Scheduled sale ($203k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.42 | 8,000 | $99K | 48.9% |
| 2 | $13.00 | 8,000 | $104K | 51.1% |
| Total | $12.71 avg | 16,000 | $203K | 100% |
| Filing → |
| PRNB | SELL | 2020-02-20 | $818K | — | Filing → |
| MAPP | SELL | 2011-09-22 | $492K | — | Filing → |
| MAPP | SELL | 2010-09-22 | $225K | — | Filing → |